Catalent Inc receives Investment Bank Analyst Rating Update
- ByInvesting.com-
Catalent (NYSE:CTLT) was cut to Neutral from Overweight with a $45 price target, down from $90 per share by JPMorgan analysts on Friday. They told investors that operational fixes...
Here is your Pro Recap of the biggest analyst cuts you may have missed today: downgrades for Nike, Foot Locker, Canadian National Railway, and Catalent.InvestingPro subscribers got...
Earnings season has been better than feared, and we highlight two firms offering differing views on the state of the economy There’s also one falling Pharma company that...
Three US banks have failed so far in 2023, marking the second, third, and fourth largest bank failures in history. But, certain stocks have outperformed the market despite the...
Equity markets in Europe, the US, and Asia had a positive week, with S&P 500 and Nasdaq performing well. 0DTE options, which are cheap and offer a way to bet on short-term...
Catalent, Inc. is a provider of development and manufacturing solutions for drug, cell and gene therapies biologics, vaccines, and consumer health products. The Company’s segments include Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. Its Biologics segment provides development and manufacturing for protein, plasmid DNA mRNA, cell therapy, viral vaccines and viral-based gene therapies. Its Softgel and Oral Technologies segment provide formulation, development, and manufacturing services for soft capsules, as well as large-scale manufacturing of oral solid dose forms. Its Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. Its Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for, drugs, biologics and clinical trials.
| Average | 43.7273 (+15.9260% Upside) |
| High | 60.0000 |
| Low | 28.0000 |
| Price | 37.7200 |
| No. of Analysts | 11 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Buy | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Neutral | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 63.69 | 63.99 | 61.27 | +2.19 | +3.56% | 7.59M | NYSE | |||
| 20.80 | 20.80 | 19.87 | +1.11 | +5.64% | 26.18K | NASDAQ | |||
| 1.73 | 1.81 | 1.72 | +0.03 | +1.76% | 16.32M | NASDAQ | |||
| 91.00 | 91.34 | 89.60 | +2.41 | +2.72% | 10.22M | NYSE | |||
| 5.36 | 5.50 | 5.21 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 70.02 | 71.99 | 69.46 | +0.93 | +1.35% | 7.52M | NASDAQ | |||
| 74.88 | 76.16 | 73.20 | +0.19 | +0.25% | 4.74M | NASDAQ | |||
| 7.77 | 7.85 | 7.56 | +0.220 | +2.91% | 317.09K | NASDAQ | |||
| 36.65 | 36.65 | 36.00 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 67.60 | 69.20 | 66.32 | +0.30 | +0.45% | 2.46M | NYSE | |||
| 1.47 | 1.4799 | 1.44 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 3.21 | 3.33 | 3.09 | -0.030 | -0.93% | 267.55K | NASDAQ | |||
| 11.40 | 11.48 | 11.40 | +0.01 | +0.09% | 4.79K | OTC Markets | |||
| 11.70 | 11.70 | 11.70 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 9.69 | 9.73 | 9.63 | +0.08 | +0.83% | 21.31K | OTC Markets |